📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells. (2016)

First Author: Abraham SA

Attributed to: Manchester Molecular Pathology Innovation Centre (MMPathIC): bridging the gap between biomarker discovery and health and wealth funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/nature18288

PubMed Identifier: 27281222

Publication URI: http://europepmc.org/abstract/MED/27281222

Type: Journal Article/Review

Volume: 534

Parent Publication: Nature

Issue: 7607

ISSN: 0028-0836